EP1.01-76 Oncomine Tumor Mutation Load Assay in NSCLC Patients from Argentina: Study Design and Feasibility von Denninghoff, V., Romano, V., Cabrerizo, R., Kuzminin, A., Wainsztein, V., Recondo, G.

Volltext

P01.11 Clinical Outcomes After Discontinuation of Immunotherapy in Patients With Non-Progressing Metastatic Lung Cancer von Cerini, M., Bluthgen, V., Peuchot, V., Rizzo, M., Rizzi, F., Kuzminin, A., Recondo, G., Faura, V., Naveira, M., Perfetti, A., Lupinacci, L., Minatta, J.

Volltext

P2.04-81 Non-Small Cell Lung Cancer Treated with Immunotherapy: Multi-Institutional Experience from Argentina von Rizzo, M., Bluthgen, M., Recondo, G., Naveira, M., Perfetti, A., Rizzi, M., Cerini, M., Kuzminin, A., Faura, M., Silva, C., Lupinacci, L., Minatta, N.

Volltext

P2.04-82 Discontinuation of Anti-PD-1/PD-L1 Antibody Therapy in the Absence of Disease Progression: Clinical Outcomes in Advanced NSCLC von Minatta, N., Bluthgen, M., Rizzo, M., Rizzi, M., Kuzminin, A., Recondo, G., Faura, M., Naveira, M., Perfetti, A., Cerini, M., Lupinacci, L.

Volltext

EP1.04-41 Efficacy of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer: A Multicentric Experience from Argentina von Rizzi, M., Minatta, N., Rizzo, M., Recondo, G., Naveira, M., Lupinacci, L., Kuzminin, A., Faura, M., Perfetti, A., Sena, S., Bluthgen, M.

Volltext

P1.04-82 Toxicity as a Clinical Marker for Efficacy of Immunotherapy in NSCLC: A Multicentric Experience from Argentina von Rizzi, M., Rizzo, M., Minatta, N., Recondo, G., Naveira, M., Lupinacci, L., Kuzminin, A., Faura, M., Perfetti, A., Sena, S., Bluthgen, M.

Volltext

P1.16-10 Real-World Efficacy of First-Line Pembrolizumab in Patients with Advanced PD-L1 High Non-Small Cell Lung Cancer in Argentina von Kuzminin, A., Minatta, N., Bluthgen, M., Rizzo, M., Naveira, M., Wainsztein, V., Lupinacci, L., Rizzi, M., Faura, M., Perfetti, A., Recondo, G.

Volltext

Oncomine Tumor Mutation Load Assay in NSCLC Patients from Argentina: Study Design and Feasibility: EP1.01-76 von Denninghoff, V, Romano, V, Cabrerizo, R, Kuzminin, A, Wainsztein, V, Recondo, G

Volltext

Efficacy of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer: A Multicentric Experience from Argentina: EP1.04-41 von Rizzi, M, Minatta, N, Rizzo, M, Recondo, G, Naveira, M, Lupinacci, L, Kuzminin, A, Faura, M, Perfetti, A, Sena, S, Bluthgen, M

Volltext

Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting von Rizzo, Manglio Miguel, Bluthgen, María Virginia, Recondo, Gonzalo, Naveira, Martin, Perfetti, Aldo, Rizzi, Florencia, Kuzminin, Alejandro, Faura, Victoria, Cerini, Matías, Videla, Alejandro, Silva, Carlos, Lupinacci, Lorena, Minatta, Nicolás

Volltext

46P PIK3CA mutation impact in prognosis of advanced HR+/HER2-negative breast cancer patients: Collaborative multicentric Argentinean real-world study (YOGA-B-01) von Mando, P., Waisberg, F.D., Rivero, S.G., Ostinelli, C.A., Winocur, M., Ripoll, J.J. Serer, Nacuzzi, G., Montenegro, M.B., Vanni, M.Y., Páez, V., Loayza, G. Guaygua, Kuzminin, A.D., Micheri, C., Costanzo, M.V., Bella, S.R., Kaen, D.L., Kowalyszyn, R.D.D., Perazzo, F.

Volltext